METHOD FOR ANTHROPOMETRIC ASSESSMENT OF RISK OF DEVELOPING HYPERPLASTIC UTERINE PROCESS IN PERIMENOPAUSAL FEMALES Russian patent published in 2014 - IPC A61B5/00 A61B5/107 

FIELD: medicine.

SUBSTANCE: 5 anthropometric characteristics of a human body are evaluated: fat component percentage, body weight index, chest roll thickness, transverse thoracic diameter, waist/hip relation. A risk of the hyperplastic uterine process is evaluated. In leprosomic women - as a sum of five productions less 1,139.61, while the sum of five productions being determined as the fat component percentage multiplied by 24.24, the body weight index multiplied by 11.22, the chest roll thickness multiplied by 34.08, the transverse thoracic diameter multiplied by 6.64, the waist/hip relation multiplied by 120.0. In mesosomic women - as a sum of five productions less 1562.43, while the sum of five productions being determined as the fat component percentage multiplied by 5.47, the body weight index multiplied by 17.31, the chest roll thickness multiplied by 5.96, the transverse thoracic diameter multiplied by 35.71, the waist/hip relation multiplied by 66.67. In megalosomic women - as a sum of five productions less 1555.13, while the sum of five productions being determined as the fat component percentage multiplied by 12.96, the body weight index multiplied by 21.04, the chest roll thickness multiplied by 14.65, the transverse thoracic diameter multiplied by 13.89, the waist/hip relation multiplied by 85.71. The risk of the hyperplastic uterine process is evaluated: 0 point and less as class 0 - individuals with a very low risk of the hyperplastic process. From 0 through 33 points as class 1 - individuals with a low risk of the hyperplastic process. From 33 through 67 points as class II - individuals with a moderate risk of the hyperplastic process. From 67 through 99 points as class III - individuals with a risk of the hyperplastic process above the average; from 99 and more as class IV - individuals with a high risk of the hyperplastic process.

EFFECT: method enables evaluating the risk of the hyperplastic uterine process individually, or for an examined sub-population by assessing the anthropometric body parameters.

5 tbl, 3 ex